Skip to content
Black FridayExtra 40% off yearly ProUse code at checkout or during your trialEnds Nov 28Claim offer →
Stock screener

DWTX Dogwood Therapeutics, Inc. stock chart & analysis

Conviction 49HealthcareScan · Fri, Nov 20, 2026

Dogwood Therapeutics, Inc. (DWTX) closed at $1.00 (-5.66%) on Nov 20, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 35, RS Rating 6, -85.8% from its 52-week high, -76.0% year to date. Sector: Healthcare · Pharmaceutical Preparations.

DWTX$1.00-5.66%
ResistanceSupportVol 14
Loading chart…
Dogwood Therapeutics, Inc.Pharmaceutical Preparationswww.virios.com ↗
Price1.00
Change-5.66%
Gap-3.77%
Rel volume0.56×
Avg volume116.36K
Avg $ vol130K
SMA 201.14
SMA 501.31
SMA 2001.84
Price vs 50-23.38%
Price vs 200-45.57%
MA stackbearish
50/200 cross—
Supertrenddown · 1.40
RSI (14)35
MACD hist0.00
MACD cross—
Stoch %K / %D21 / 31
ADX (14)16
+DI / −DI16 / 24
RSI divergence—
MACD divergence—
ATR %13.77%
ADR %12.22%
52w high7.04
52w low0.9010
From 52w high-85.80%
Above 52w low+10.99%
New 52w highNo
SqueezeOn · 11d
Bollinger width30.57%
%B0.10
Donchian pos20.67%
Donchian high1.38
Donchian low0.9010
AVWAP (52w high)2.01
vs AVWAP high-50.36%
AVWAP (52w low)1.11
vs AVWAP low-9.75%
OBV trendDown
Chaikin MF (20)-0.24
Today vs 20d0.56×
Avg vol (14d)143.27K
Avg vol (20d)116.36K
Avg $ vol (20d)130K
Market cap38.23M
RS Rating6 / 99
RS 3m (vs SPY)-51.40%
RS 6m (vs SPY)-36.76%
RS line new highNo
Trend template0/8
Technical rank21.6
1 week-9.91%
1 month-10.71%
3 months-60.94%
6 months-44.13%
1 year-83.25%
YTD-75.96%
P/E-1.12
P/B0.60
P/S—
P/FCF—
EPS-7.13
Div yield—
ROE-53.42%
ROA-45.31%
Debt/Eq—
Current2.78
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-177.39%
Price target—
Target upside—
Analyst rating—
Institutional10.02%
Ent. value33.28M
Revenue100K
Net income-4.88M
Gross profit11.9K
Free cash flow—
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out33.63M
Employees8
ListedThu, Dec 17, 2020
Free float8.56M
Float %25.7%
Short interest—
Days to cover—
Short volume37.2%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction49 / 100
Pattern quality—
Tech rank21.6 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.63
Support0.9605
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

DWTX technical analysis

Trend

DWTX is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 23.4% below the 50-day ($1.31) and 45.6% below the 200-day ($1.84). ADX(14) at 16 points to a weak trend — more range than direction. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 35, in the bearish half of its range. The MACD histogram is positive. Its RS Rating of 6 puts its weighted 12-month performance ahead of about 6% of the US market.

Volume and volatility

Volume on the latest session ran 0.6× its 20-day average. It trades about $130,000 a day on average. ATR(14) is $0.1377, 13.8% of price — its typical daily range. Bollinger Bands are in a squeeze (11 sessions) — volatility is compressed. On-balance volume is trending down. Chaikin Money Flow (-0.24) shows distribution.

Key levels

The chart pattern's support is $0.9605 and its resistance $1.63. The 52-week range is $0.9010 to $7.04; price is 85.8% below the high and 11.0% above the low. The VWAP anchored at the 52-week high is $2.01, above price.

Performance

DWTX returned -9.9% (1 week), -10.7% (1 month), -60.9% (3 months), -44.1% (6 months), -83.3% (1 year), -76.0% (year to date).

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Pharmaceutical Preparations · Listed 2020 · 8 employees

Insider activity

SEC Form 4 transactions in DWTX

InsiderSideShares
Sealbond Ltd
Director · Common Stock · 2026-10-26
Grant4.1M

SEC filings

EDGAR filings in DWTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.